Atherosclerosis Cardiovascular Disease Clinical Trials in Amsterdam
2 recruitingAmsterdam, Netherlands
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
Chronic Kidney DiseaseAtherosclerosis Cardiovascular Disease
Eli Lilly and Company7,140 enrolled568 locationsNCT07241390
Recruiting
Evaluating Atherosclerotic Disease Progression in Patients With Diabetes Mellitus
Type 2 DiabetesCoronary Artery Disease (CAD)Atherosclerosis Cardiovascular Disease
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1,000 enrolled2 locationsNCT07237685